Clinical Trial Update: A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of DC50292A Tablet in patients with MTAP-deleted advanced or metastatic solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• DC50292A Tablet

Snippet

Sponsor: Heronova Pharmaceuticals | Conditions: Solid Tumor Malignancies | Phase 1 | Status: RECRUITING